Tag Archives: U.S.

Groupons For Medical Treatment? Welcome To Today’s U.S. Health Care

This story also ran on NPR. This story can be republished for free (details). Emory University medical fellow Dr. Nicole Herbst was shocked when she saw three patients who came in with abnormal results from chest CT scans they had bought on Groupon. Yes, Groupon — the online coupon mecca that also sells discounted fitness… Read More »

Co-owner, ex-employee of pharmacy in U.S. meningitis outbreak acquitted

BOSTON (Reuters) – A federal judge on Friday tossed the convictions of a co-owner and former employee of a Massachusetts compounding pharmacy accused of conspiring to help it evade regulatory oversight before its drugs caused a deadly 2012 fungal meningitis outbreak. FILE PHOTO: Gregory Conigliaro, a co-owner of the now-defunct New England Compounding Center, enters… Read More »

8-year-old African child who was flown to the U.S. for surgery by NBA star Dikembe Mutombo has died

(Photo by Marcus Ingram/Getty Images for UNICEF) Former NBA star Dikembe Mutombo is mourning the death of the 8-year-old African boy that he flew to the United States earlier this month for surgery to remove a tumor. The child, Matadi Sela Petit of Kinshasa, Congo, died after suffering a “rare and unpredictable genetic reaction to… Read More »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »